Heart registry for patients after coronary interventions in South East Netherlands
South East (Zuid Oost) Netherlands Heart Registry (ZON-HR)
This study is creating a registry to help doctors better understand and treat patients in South East Netherlands who have had heart procedures, aiming to reduce their risk of future heart problems.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 99999 (estimated) |
| Sex | All |
| Sponsor | Radboud University Medical Center Academic / other |
| Locations | 4 sites (Heerlen, Limburg and 3 other locations) |
| Trial ID | NCT06512493 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a comprehensive registry for patients undergoing percutaneous coronary intervention (PCI) for chronic and acute coronary syndromes. It focuses on assessing the quality of secondary prevention and personalized medicine strategies to reduce the risk of ischemic events post-PCI. By analyzing various risk factors such as thrombotic, lipid, inflammation, and diabetic factors, the study seeks to improve patient outcomes through tailored treatment plans. The registry will collect data to enhance understanding and management of residual risks associated with coronary artery disease.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone percutaneous coronary intervention for chronic or acute coronary syndromes.
Not a fit: Patients who have not undergone PCI or those with conditions unrelated to coronary artery disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved personalized treatment strategies that significantly reduce complications and enhance the prognosis for patients after PCI.
How similar studies have performed: Other studies focusing on personalized medicine and secondary prevention in coronary artery disease have shown promising results, indicating that this approach is both relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
No in- or exclusion criteria are applied to gain 100% registration in order to prevent bias.
Where this trial is running
Heerlen, Limburg and 3 other locations
- ZuyderlandMC — Heerlen, Limburg, Netherlands (Recruiting)
- MaastrichtUMC+ — Maastricht, Limburg, Netherlands (Recruiting)
- VieCuri — Venlo, Limburg, Netherlands (Recruiting)
- Radboud University Medical Centre — Nijmegen, Netherlands (Recruiting)
Study contacts
- Study coordinator: van Geuns
- Email: robertjan.vangeuns@radboudumc.nl
- Phone: (024) 3614153
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.